Edgewise Therapeutics stock consolidates near key support as bullish momentum persists

Traders Union
All News
Companies
Edgewise Therapeutics up 1.05% today

Highlights

EWTX maintains a bullish technical structure with price above key moving averages across all timeframes.
Momentum indicators (MACD, RSI, CCI) support a positive trend, though ADX and Stoch RSI suggest moderation, not euphoria.
Expected range for the coming week is $38.00 to $44.00, with strong probability of upward price movement toward resistance near $44.00.

Bullish alignment as price holds above multi-timeframe supports

EWTX is trading at $39.56, which is above the MA-20 ($37.09), MA-50 ($34.86), and MA-200 ($27.01), confirming a bullish price structure across short-, medium-, and long-term timeframes. The Ichimoku Kijun on D1 stands at $37.39, acting as immediate support, with near-term support at $37.09 (MA-20) and key support at $34.86 (MA-50), while immediate resistance is found at $39.31 (MA-10) and key resistance sits at $40.77 (MA-5 cluster).

Buyer dominance moderates as momentum stays positive despite weekly pullback

On D1, MACD signals ongoing bullish momentum, while ADX remains neutral, suggesting trend strength is subdued but not negative. RSI is in bullish territory at 56.98, and CCI also supports a positive tone, but Stoch RSI is neutral, signaling neither overbought nor oversold conditions at this timeframe. BBP indicates strong buyer dominance intraday, although overbought readings on the D1 BBP warrant some caution. In today's session, EWTX is up 1.05%, showing a modest recovery from recent declines. Over the past week, EWTX fell $1.90 (a 4.58% decline) from its previous weekly close of $41.46, with the price now at the very bottom of the weekly range and weekly volatility standing at 10.42%. This places the stock near weekly support following a steady decline from last week's high.

Upside probability high as technical signals favor near-term consolidation

For the coming week, the expected price range is $38.00 to $44.00, centered around the current level and well within 20% of the present price, staying anchored between the 52-week low of $12.30 and the high of $43.93. With all key W1 indicators (RSI, ADX, MACD, MA-50) flashing "Buy," the probability of a price increase is very high (more than 80%), while the likelihood of a decline is very low. Baseline scenario suggests consolidation between $38.00 and $44.00. A bullish move would see EWTX break above $44.00, targeting the 52-week high. A bearish scenario could develop if the price drops below $38.00, exposing support toward the $35.00 area.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Edgewise Therapeutics maintained a strong bullish technical outlook, with momentum and sentiment heavily favoring further upside. This perspective remains relevant as current developments emphasize the importance of watching for sustained momentum above recent highs, with any loss of trend strength potentially signaling a shift in near-term market risk.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.